Prep for USMLEPrep for USMLE Forum
   Forum    Step 1  Step 2 CK Step 2 CS Step 3  Match  IMGs Resources Search






Previous Topic | Next Topic  Diabetes Q 




 
Kaplan Qbank USMLE



Author32 Posts
  #26

gringringrin

  #27

Answer is D.

Diabetic nephropathy is the leading cause of end stage renal disease and the HbA1C indicates poorly controlled diabetes. As the patients poorly controlled diabetes starts to damage the kidneys, proteins start to leak into the urine --> macroalbuminemia indicates end stage renal disease. Also in chronic renal disease, you will see increased BUN and creatinine. Normocytic anemia is caused by lack of erythropoietin production, which is due to the kidney damage. Retinopathy is just another clue indicating microvascular damage, just like nephropathy. Malaise, fatigue, and chest pain are symptoms that also support anemia.

  #28

yes D nod

  #29

Answer is D. I have a question for you guys. Same Patient but now the questions says that the patient has a microcytic anemia(along with renal failure) what is the best reatment?

Erythropoietin or iron?


___________________
Mr. Physiology. An answering machine.

  #30

paganini wrote:
Answer is D. I have a question for you guys. Same Patient but now the questions says that the patient has a microcytic anemia(along with renal failure) what is the best reatment?

Erythropoietin or iron?

Erythropoietin & iron

Edited by new_n_lost on 07/02/07 - 05:26 PM

___________________
FORUM RULES-- Those who believe in telekinesis, raise my hand. I get enough exercise just by pushing my luck --P4U World.." The pure and simple truth is rarely pure and never simple."

  #31

grinyes

___________________
Mr. Physiology. An answering machine.

  #32

a normocytic anemia can progress to microcytic in renal failure

___________________
Mr. Physiology. An answering machine.







You don't have permission to post.




Login or Register to post messages in this topic





















Contact | Leaders | Disclaimer | Privacy

Copyright @ Prep for USMLE. All rights reserved.